These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Identifying factors that affect patients' willingness to pay for inhaled insulin. Pinto SL; Holiday-Goodman M; Black CD; Lesch D Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826 [TBL] [Abstract][Full Text] [Related]
64. Recent advances in the development of an inhaled insulin product. Valente AX; Langer R; Stone HA; Edwards DA BioDrugs; 2003; 17(1):9-17. PubMed ID: 12534317 [TBL] [Abstract][Full Text] [Related]
65. [Cutaneous complications of insulin therapy. A drug-induced condition on the decline]. Piérard-Franchimont C; Hermanns-Lê T; Scheen AJ; Piérard GE Rev Med Liege; 2005; 60(5-6):564-5. PubMed ID: 16035329 [TBL] [Abstract][Full Text] [Related]
66. Afrezza inhaled insulin: the fastest-acting FDA-approved insulin on the market has favorable properties. Klonoff DC J Diabetes Sci Technol; 2014 Nov; 8(6):1071-3. PubMed ID: 25355710 [No Abstract] [Full Text] [Related]
67. The international study of insulin and cancer. Grimaldi-Bensouda L; Marty M; Pollak M; Cameron D; Riddle M; Charbonnel B; Barnett AH; Boffetta P; Boivin JF; Evans M; Rossignol M; Benichou J; Abenhaim L; Lancet; 2010 Sep; 376(9743):769-70. PubMed ID: 20816540 [No Abstract] [Full Text] [Related]
68. Pulmonary insulin delivery--state of the art 2007. Skyler JS Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S1-3. PubMed ID: 17563297 [No Abstract] [Full Text] [Related]
69. Inhaled insulin no longer recommende as routine diabetes treatment. Mayor S BMJ; 2006 Jul; 333(7557):14. PubMed ID: 16809702 [No Abstract] [Full Text] [Related]
72. Insulin for the uninitiated. Chowdhury TA; Wright R; Charlton M Clin Med (Lond); 2014 Dec; 14(6):623-9. PubMed ID: 25468848 [TBL] [Abstract][Full Text] [Related]
73. Safer administration of insulin: summary of a safety report from the National Patient Safety Agency. Lamont T; Cousins D; Hillson R; Bischler A; Terblanche M BMJ; 2010 Oct; 341():c5269. PubMed ID: 20943723 [No Abstract] [Full Text] [Related]
74. Approval of inhaled insulin in Europe and United States. Charlesworth B BMJ; 2006 Mar; 332(7543):730. PubMed ID: 16565143 [No Abstract] [Full Text] [Related]
76. [New information of oral insulin, nasal insulin and inhaled insulin]. Okada Y Nihon Rinsho; 2012 May; 70 Suppl 3():678-81. PubMed ID: 22768597 [No Abstract] [Full Text] [Related]
77. The Need for Faster Insulin. Muchmore DB J Diabetes Sci Technol; 2017 Jan; 11(1):157-159. PubMed ID: 28264172 [TBL] [Abstract][Full Text] [Related]
78. A person-centred approach to insulin initiation and intensification. Kalra S J Indian Med Assoc; 2013 Nov; 111(11):743-5, 750. PubMed ID: 24968482 [No Abstract] [Full Text] [Related]
79. Hypoglycemia: the dangerous side of great control. Sherifali D Can J Diabetes; 2015 Nov; 39 Suppl 4():1-5. PubMed ID: 26541484 [No Abstract] [Full Text] [Related]